Human prostate carcinoma cells produce extracellular heparanase

Journal of Surgical Research

Volumn 67, Issue 1, 1997, Pages 98-105

  Kosir, Mary Ann ^a   Quinn, Christiane C V ^a   Zukowski, Kim L ^a   Grignon, David J ^b   Ledbetter, Steven ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; GLUCAN SYNTHASE; HEPARANASE; HEPARIN; PROTEOHEPARAN SULFATE;

ARTICLE; BASEMENT MEMBRANE; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROSTATE CARCINOMA; TISSUE SECTION;

EID: 0030937093     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.4976     Document Type: Article

References (28)

1. 1. Mignatti, P., Robbins, E., and Rifkin, D. B. Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade. Cell 47: 487, 1986.
2. 2. Pauli, B. U., and Knudson, W. Tumor invasion: A consequence of destructive and compositional matrix alterations. Human Pathol. 19: 628, 1988.
3. 3. Poole, A. R. Proteoglycans in health and disease: Structures and functions. Biochem. J. 236: 1, 1986.
4. 4. Hardingham, T. E., and Fosang, A. J. Proteoglycans: Many forms and many functions. FASEB J. 6: 861, 1992.
5. 5. Scott, J. E. Supramolecular organization of extracellular matrix glycosaminoglycans, in vitro and in the tissues. FASEB J. 6: 2639, 1992.
6. 6. Laskov, R., Michaeli, R., Sharir, H., et al. Production of heparanase by normal and neoplastic murine B-lymphocytes. Int. J. Cancer 47: 92, 1991.
7. 7. Ricoveri, W., and Cappelletti, R. Heparan sulfate endoglycosidase and metastatic potential in murine fibrosarcoma and melanoma. Cancer Res. 46: 3855, 1986.
8. 8. Nakajima, M., Irimura, T., and Nicolson, G. L. Heparanases and tumor metastasis. J. Cell. Biochem. 36: 157, 1988.
9. 9. Nakajima, M., Morikawa, K., Fabra, A., et al. Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J. Natl. Cancer Inst. 82: 1890, 1990.
10. 10. Vlodavsky, I., Fuks, Z., and Bar-Ner, M. Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: Relationship to tumor cell metastasis. Cancer Res. 43: 2704, 1983.
11. 11. Peretz, T., Antebi, S. U., Beller, U., et al. Maintenance on extracellular matrix and expression of heparanase activity by human ovarian carcinoma cells from biopsy specimens. Int. J. Cancer 45: 1054, 1990.
12. 12. Ishai-Michaeli, R., Eldo, A., and Vlodavsky, I. Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix. Cell Regul. 1: 833, 1990.
13. 13. Bernfield, M., and Hooper, K. C. Possible regulation of FGF activity by syndecan, an integral membrane heparan sulfate proteoglycan. Ann. N. Y. Acad. Sci. 638: 182, 1991.
14. 14. Salmivirta, M., Heino, J., and Jalkanen, M. Basic fibroblast growth factor - syndecan complex at cell surface or immobilized to matrix promotes cell growth. J. Biol. Chem. 267: 17606, 1992.
15. 15. Hoogewerf, A. J., Leone, J. W., Reardon, I. M., Howe, W. J., Asa, D., Heinrikson, R. L., and Ledbetter, S. R. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes. J. Biol. Chem. 270: 3268, 1995.
16. 16. Castor, C. W., Miller, J. W., and Walz, D. A. Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 80: 767, 1983.
17. 17. Castor, C. W., Andrews, P. C., Swartz, R. D., Ellis, S. G., Hossler, P. A., Clark, M. R., Matteson, E. L., and Sachter, E. F. The origin, variety, distribution and biologic fate of connective tissue activating peptide-III isoforms: Characteristics in patients with rheumatic, renal, and arterial disease. Arthritis Rheum. 36: 1142, 1993.
18. 18. Kozlowski, J. M., Fidler, I. J., Campbell, D., et al. Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res. 44: 3522, 1984.
19. 19. Lee, C., Shevrin, D. H., and Kozlowski, J. M. In vivo and in vitro approaches to study metastasis in human prostatic cancer. Cancer Metastasis Rev. 12: 21, 1993.
20. 20. Stephenson, R. A., Dinney, C. P. N., Gohji, K., et al. Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J. Natl. Cancer Inst. 84: 951, 1992.
21. 21. Ware, J. L., and Maygarden, S. J. Metastatic diversity in human prostatic carcinoma: Implications of growth factor receptors for the metastatic phenotype. Pathol. Immunopathol. Res. 8: 231, 1989.
22. 22. Kosir, M. A., and Quinn, C. C. V. Sorting of heparan sulfate proteoglycan into matrix compartments of prostate adenocarcinoma cells. J. Surg. Res. 58: 46, 1995.
23. 23. Kosir, M. A., and Quinn, C. C. V. Increased heparan sulfate proteoglycan in metastatic human prostate carcinoma cells. Submitted for publication.
24. 24. Hassell, J. R., Leyshon, W. C., Ledbetter, S. R., Tyree, B., Suzuki, S., Kato, M., Kimata, K., and Kleinman, H. K. Isolation of two forms of basement membrane proteoglycans. J. Biol. Chem. 260: 8098, 1985.
25. 25. Wight, T. N., Heinegard, D. K., and Hascall, V. C. Proteoglycans: Structure and function. In E. D. Hay (Ed.), Cell Biology of Extracellular Matrix, 2nd ed. New York: Plenum, 1991. Pp. 63-66.
26. 26. Lark, M. W., and Culp, L. A. Modification of proteoglycans during maturation of fibroblast substratum adhesion sites. Biochemistry 22: 2289, 1983.
27. 27. Kosir, M. A., and Culp, L. A. Adhesive interactions between malignant cells and the extracellular matrix. In L. M. Nyhus (Ed.), Surgery Annual, Appleton & Lange, 1990. Pp. 25-48.
28. 28. Culp, L. A., Mugnai, G., Lewandowska, K., Vallen, E. A., Kosir, M. A., Houmiel, K. L. Heparan sulfate proteoglycans of ras-transformed 3T3 or neuroblastoma cells: Differing functions in adhesion on fibronectin. Ann. N. Y. Acad. Sci. 556: 194, 1989.